Tag: Cancer: Lung
ASCO: New Assays May Detect Early Lung Cancer in Blood
Targeted sequencing, whole-genome sequencing, whole-genome bisulfite sequencing show potential
ASCO: Pembrolizumab Superior for Initial Tx of Advanced NSCLC
Improved overall survival versus chemotherapy regardless of the PD-L1 tumor proportion score
Prediction Tool Helps Tailor Lung Cancer Screening to Patients
Researchers create web-based decision tool to facilitate personalized discussions
Lung Cancer Incidence Higher for Young Women Than Young Men
Crossover in sex-specific rates among U.S. non-Hispanic whites born since 1965
ASCO: Few Eligible Smokers Had CT Screen for Lung CA in 2016
Most eligible smokers populated in South, which had most screening sites but low screening rate
Risk Models Help Select Ever Smokers for Lung CA Screening
Four models were well-calibrated and had higher AUCs than five that overestimated risk
CKAP4 Is Novel Serodiagnostic Marker for Lung Cancer
Serum CKAP4 levels of lung cancer patients significantly higher than those of healthy controls
Clinical Upstaging of NSCLC Seen With Each Progressive Week
For clinical stage 1 NSCLC, 21.7 percent of patients upstaged after 1 week; 31.5 percent after 8 weeks
Adjuvant Pembrolizumab Beneficial in Metastatic NSCLC
And, nivolumab plus ipilimumab linked to better survival in NSCLC with high tumor mutational burden
Lag in Progress Against Lung CA Mortality in Midwest, Appalachia
Findings based on rates among women versus steady decline seen nationally
